TWO SIGMA INVESTMENTS, LP - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 151 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$1,428,776
-12.7%
1,457,935
+23.9%
0.00%0.0%
Q2 2023$1,635,819
-3.2%
1,176,848
+10.7%
0.00%
-20.0%
Q1 2023$1,690,008
-82.4%
1,062,898
-30.9%
0.01%
-83.3%
Q4 2022$9,579,647
+33.8%
1,537,664
+43.9%
0.03%
+25.0%
Q3 2022$7,159,000
+194.4%
1,068,438
+179.4%
0.02%
+200.0%
Q2 2022$2,432,000
+274.7%
382,403
+173.3%
0.01%
+300.0%
Q1 2022$649,000
-62.1%
139,899
-59.2%
0.00%
-50.0%
Q4 2021$1,713,000
+25.5%
342,647
+604.0%
0.00%0.0%
Q1 2021$1,365,000
+1.0%
48,670
-6.3%
0.00%0.0%
Q4 2020$1,351,000
+91.9%
51,964
+174.5%
0.00%
+100.0%
Q3 2020$704,000
-51.2%
18,930
-32.7%
0.00%
-71.4%
Q2 2020$1,443,000
-0.3%
28,132
-28.8%
0.01%
+40.0%
Q3 2019$1,447,000
-78.5%
39,484
-72.7%
0.01%
-78.3%
Q2 2019$6,735,000
+583.8%
144,774
+490.4%
0.02%
+666.7%
Q1 2019$985,000
-69.5%
24,522
-64.9%
0.00%
-75.0%
Q2 2017$3,234,000
+1.6%
69,877
-22.5%
0.01%
+9.1%
Q1 2017$3,182,000
-85.8%
90,118
-67.1%
0.01%
-89.4%
Q2 2015$22,362,000
+73.8%
273,502
+96.8%
0.10%
+65.1%
Q1 2015$12,870,000
+731.9%
138,983
+263.4%
0.06%
+600.0%
Q4 2014$1,547,00038,2500.01%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2022
NameSharesValueWeighting ↓
Meditor Group Ltd 3,791,300$3,715,4744.82%
Two Seas Capital LP 7,672,170$7,518,7271.51%
Parkman Healthcare Partners LLC 1,997,071$1,957,1300.36%
Monaco Asset Management SAM 1,171,779$1,148,3430.34%
TANG CAPITAL MANAGEMENT LLC 1,850,000$1,813,0000.26%
Ikarian Capital, LLC 1,737,636$1,702,8830.20%
PLATINUM INVESTMENT MANAGEMENT LTD 3,189,517$3,125,7270.12%
GSA CAPITAL PARTNERS LLP 1,116,655$1,0940.09%
XTX Topco Ltd 519,129$508,7460.09%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 60,000$58,8000.08%
View complete list of ESPERION THERAPEUTICS INC NE shareholders